Bibiana Cabrera

3.1k total citations
40 papers, 910 citations indexed

About

Bibiana Cabrera is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Cognitive Neuroscience. According to data from OpenAlex, Bibiana Cabrera has authored 40 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 11 papers in Biological Psychiatry and 9 papers in Cognitive Neuroscience. Recurrent topics in Bibiana Cabrera's work include Schizophrenia research and treatment (25 papers), Bipolar Disorder and Treatment (11 papers) and Tryptophan and brain disorders (11 papers). Bibiana Cabrera is often cited by papers focused on Schizophrenia research and treatment (25 papers), Bipolar Disorder and Treatment (11 papers) and Tryptophan and brain disorders (11 papers). Bibiana Cabrera collaborates with scholars based in Spain, United States and United Kingdom. Bibiana Cabrera's co-authors include Miquel Bernardo, Miquel Bioque, Gisela Mezquida, Manuel J. Cuesta, Mara Parellada, Ana González‐Pinto, António Lobo, Eduard Vieta, Iluminada Corripio and Josefina Castro‐Fornieles and has published in prestigious journals such as PLoS ONE, Psychological Medicine and Journal of Affective Disorders.

In The Last Decade

Bibiana Cabrera

38 papers receiving 904 citations

Peers

Bibiana Cabrera
J.P. Lindenmayer United States
Max Lam United States
René S. Kahn Netherlands
Hiske E. Becker Netherlands
Bibiana Cabrera
Citations per year, relative to Bibiana Cabrera Bibiana Cabrera (= 1×) peers Anna Mané

Countries citing papers authored by Bibiana Cabrera

Since Specialization
Citations

This map shows the geographic impact of Bibiana Cabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bibiana Cabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bibiana Cabrera more than expected).

Fields of papers citing papers by Bibiana Cabrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bibiana Cabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bibiana Cabrera. The network helps show where Bibiana Cabrera may publish in the future.

Co-authorship network of co-authors of Bibiana Cabrera

This figure shows the co-authorship network connecting the top 25 collaborators of Bibiana Cabrera. A scholar is included among the top collaborators of Bibiana Cabrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bibiana Cabrera. Bibiana Cabrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabrera, Bibiana, et al.. (2024). SWITCHING PROPHYLAXIS DURING AN IMMUNE TOLERANCE INDUCTION EVOLVING WITH FAILURE: A CASE REPORT FROM A BRAZILIAN HEMOPHILIA TREATMENT CENTER. Hematology Transfusion and Cell Therapy. 46. S563–S564.
2.
Bernardo, Miquel, et al.. (2022). Dried Blood Spot (DBS) as a useful tool to improve clozapine, aripiprazole and paliperidone treatment: From adherence to efficiency. Revista de Psiquiatría y Salud Mental (English Edition). 15(4). 230–237. 3 indexed citations
3.
Amoretti, Sílvia, Adriane Ribeiro Rosa, Gisela Mezquida, et al.. (2020). The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses. Psychological Medicine. 52(3). 526–537. 19 indexed citations
4.
Bioque, Miquel, Sergi Mas, Maria C. Costanzo, et al.. (2019). Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis. European Neuropsychopharmacology. 29(6). 786–794. 15 indexed citations
5.
Alberich, Susana, Mara Parellada, Bibiana Cabrera, et al.. (2019). Evolution of BDNF Full-Length/Truncated Receptor Ratio and Cognitive/General Functioning After a First Episode of Psychosis. Neuropsychiatry. 9(1). 1 indexed citations
6.
Escartí, María J., Gracián García‐Martí, Roberto Sanz‐Requena, et al.. (2019). Auditory hallucinations in first-episode psychosis: A voxel-based morphometry study. Schizophrenia Research. 209. 148–155. 11 indexed citations
7.
Gassó, Patricia, Sergi Mas, Miquel Bioque, et al.. (2018). Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis. Journal of Psychopharmacology. 32(6). 702–710. 6 indexed citations
8.
Torrent, Carla, María Reinares, Anabel Martínez‐Arán, et al.. (2018). Affective versus non-affective first episode psychoses: A longitudinal study. Journal of Affective Disorders. 238. 297–304. 26 indexed citations
9.
Ballesteros, Alejandro, Ana M. Sánchez-Torres, Jose M. López-Ilundain, et al.. (2018). Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?. Psychological Medicine. 48(13). 2247–2256. 45 indexed citations
10.
Bernardo, Miquel, Miquel Bioque, Bibiana Cabrera, et al.. (2017). Modelling gene-environment interaction in first episodes of psychosis. Schizophrenia Research. 189. 181–189. 39 indexed citations
11.
Bioque, Miquel, María Paz García‐Portilla, Clemente García‐Rizo, et al.. (2017). Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis. Schizophrenia Research. 193. 188–196. 47 indexed citations
12.
Puig, Olga, Immaculada Baeza, Elena de la Serna, et al.. (2017). Persistent Negative Symptoms in First-Episode Psychosis. The Journal of Clinical Psychiatry. 78(9). 1414–1422. 25 indexed citations
13.
Mané, Anna, Daniel Bergé, María José Penzol, et al.. (2017). Cannabis use, COMT, BDNF and age at first-episode psychosis. Psychiatry Research. 250. 38–43. 23 indexed citations
14.
Fraguas, David, Covadonga M. Díaz‐Caneja, Iluminada Corripio, et al.. (2017). Gene-environment interaction as a predictor of early adjustment in first episode psychosis. Schizophrenia Research. 189. 196–203. 10 indexed citations
15.
Mezquida, Gisela, Bibiana Cabrera, Anabel Martínez‐Arán, Eduard Vieta, & Miquel Bernardo. (2017). Detection of early psychotic symptoms: Validation of the Spanish version of the “Symptom Onset in Schizophrenia (SOS) inventory”. Psychiatry Research. 261. 68–72. 5 indexed citations
16.
García‐Rizo, Clemente, Emilio Fernández-Egea, Cristina Oliveira, et al.. (2017). Metabolic syndrome or glucose challenge in first episode of psychosis?. European Psychiatry. 41(1). 42–46. 22 indexed citations
17.
Cabrera, Bibiana, Miquel Bioque, Rafael Penadés, et al.. (2016). Cognition and psychopathology in first-episode psychosis: are they related to inflammation?. Psychological Medicine. 46(10). 2133–2144. 35 indexed citations
18.
Amoretti, Sílvia, Miquel Bernardo, Caterina del Mar Bonnín, et al.. (2016). The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study. European Neuropsychopharmacology. 26(10). 1638–1648. 73 indexed citations
19.
Bioque, Miquel, Bibiana Cabrera, Borja García‐Bueno, et al.. (2016). Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis. Journal of Psychiatric Research. 75. 14–21. 17 indexed citations
20.
Bioque, Miquel, Adrián LLerena, Bibiana Cabrera, et al.. (2015). A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project. The International Journal of Neuropsychopharmacology. 19(4). pyv121–pyv121. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026